Phase II Trial of SarCNU in Malignant Glioma: Unexpected Pulmonary Toxicity with a Novel Nitrosourea: A phase II trial of the national cancer institute of canada clinical trials group

By Webster Marc   Cairncross Gregory   Gertler Stan   Perry James   Wainman Nancy   Eisenhauer Elizabeth  

Investigational New Drugs, Vol. 23, Iss. 6, 2005-12 ,pp. : 591-596

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Trials Registries and Results Reporting: 30 April-1 May 2007; Washington, DC

By Crawley Francis P.  

International Journal of Pharmaceutical Medicine, Vol. 21, Iss. 4, 2007-01 ,pp. : 295-296

Adis International

Access to resources Recommend Favorite

Are Sex Differences in Outcomes of Patients with ACS from Observational Registries Similar to the Findings from Randomized Clinical Trials?

By  

Current Pharmaceutical Design, Vol. 22, Iss. 25, 2016-07 ,pp. : 3779-3789

Bentham Science Publishers

Access to resources Recommend Favorite

Improving clinical trial sampling for future research – an international approach: outcomes and next steps from the DIA future use sampling workshop 2011

By Warner Amelia Wall   Bienfait Karina L   Bledsoe Marianna   Burckart Gilbert   Flamion Bruno   Knoppers Bartha   Nelsen Anita J   Rudman Allen   Sieffert Nicole J   Uyama Yoshiaki  

Pharmacogenomics, Vol. 14, Iss. 1, 2013-01 ,pp. : 103-112

Future Medicine

Access to resources Recommend Favorite

Paliperidone: A Review of Clinical Trial Data and Clinical Implications

By Wang Sheng-Min  

Clinical Drug Investigation, Vol. 32, Iss. 8, 2012-08 ,pp. : 497-512

Adis International

Access to resources Recommend Favorite